Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 8, 2017
Prevalence of Earlobe Creases and Their Association With History of Cardiovascular Disease in Patients Undergoing Hemodialysis: A Cross-Sectional StudyMinako Wakasugi, Junichiro James Kazama, Kazuko Kawamura, et al.
Atherosclerosis|September 7, 2019
Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patientsMika Hori, Naotaka Ohta, Atsushi Takahashi, et al.
Kidney International Reports|November 9, 2020
Fibroblast Growth Factor 23 and Mortality Among Prevalent Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns StudyHirotaka Komaba, Douglas S Fuller, Masatomo Taniguchi, et al.
BMJ Open Respiratory Research|May 20, 2020
Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trialToru Arai, Hiroshi Kida, Yoshitaka Ogata, et al.
Clinical and Experimental Nephrology|March 21, 2023
Assessing fluid volume and determining outcomes of acute heart failure using plasma human atrial natriuretic peptideYuya Suzuki, Tadashi Otsuka, Yuki Yoshioka, et al.
BMJ Open Respiratory Research|July 30, 2021
Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulinToru Arai, Hiroto Matsuoka, Masaki Hirose, et al.
Internal Medicine (Tokyo, Japan)|July 5, 2023
Systemic Amyloid A Amyloidosis Secondary to Xanthogranulomatous PyelonephritisMasato Habuka, Mizusa Nishikiori, Chihiro Oikawa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2011
Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosisSuguru Yamamoto, Patricia G Yancey, Yiqin Zuo, et al.
BMC Cancer|July 20, 2012
Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding studySeigo Minami, Takashi Kijima, Ryo Takahashi, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2012
Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancerTakayuki Shiroyama, Takashi Kijima, Kiyoshi Komuta, et al.
Pageof 17